bepotastine besilate 1.5 % Ophthalmic Solution
- RxCUI
- 863038
- RxNorm name
- bepotastine besilate 1.5 % Ophthalmic Solution
- Display name
- bepotastine besilate 1.5 % Ophthalmic Solution
- Full name
- bepotastine besilate 1.5 % Ophthalmic Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bepotastine Besilate | BEPOTASTINE BESILATE | Somerset Therapeutics, LLC | cd6a061d-8ad7-4ad1-b039-1e3aa3435d32 | 2024-10-10 | Warnings, Adverse reactions | 863038 |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Bausch & Lomb Americas Inc. | 70430ab5-cd0a-451e-acab-347a2f981898 | 2024-08-20 | Warnings, Adverse reactions | 863038 |
| Bepotastine Besilate Ophthalmic Solution 1.5% | BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% | Alembic Pharmaceuticals Inc. | f68306a9-80ec-4bc5-8c00-1e1328f21e36 | 2023-07-21 | Warnings, Adverse reactions | 863038 |
| Bepotastine Besilate Ophthalmic Solution 1.5% | BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% | Alembic Pharmaceuticals Limited | de111d74-c740-47b3-adc7-4b855df2c561 | 2023-07-21 | Warnings, Adverse reactions | 863038 |
| Bepreve | BEPOTASTINE BESILATE | Bausch & Lomb Incorporated | 68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6 | 2022-08-31 | Warnings, Adverse reactions | 863038 |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Bausch & Lomb Incorporated | 995f4fe0-d861-4137-8090-a8ffc71c46f4 | 2020-12-31 | Warnings, Adverse reactions | 863038 |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Mylan Pharmaceuticals Inc. | 75178670-aa57-45f9-94d5-efcf8305e683 | 2018-03-20 | Warnings, Adverse reactions | 863038 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 14 | These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2009 | 20220831 |
| 68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 14 | These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2009 | 20220831 |
| 68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 14 | These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2009 | 20220831 |
| cd6a061d-8ad7-4ad1-b039-1e3aa3435d32 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION BEPOTASTINE BESILATE ophthalmic solution 1.5%, for topical ophthalmic use Initial U.S. Approval:2009 | 20241010 |
| cd6a061d-8ad7-4ad1-b039-1e3aa3435d32 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION BEPOTASTINE BESILATE ophthalmic solution 1.5%, for topical ophthalmic use Initial U.S. Approval:2009 | 20241010 |
| cd6a061d-8ad7-4ad1-b039-1e3aa3435d32 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION BEPOTASTINE BESILATE ophthalmic solution 1.5%, for topical ophthalmic use Initial U.S. Approval:2009 | 20241010 |
| 70430ab5-cd0a-451e-acab-347a2f981898 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 4 | These highlights do not include all the information needed to use Bepotastine Besilate Ophthalmic Solution safely and effectively. See full prescribing information for Bepotastine Besilate Ophthalmic Solution. Bepotastine Besilate Ophthalmic Solution, for topical ophthalmic use Initial U.S. Approval: 2009 | 20240820 |
| 70430ab5-cd0a-451e-acab-347a2f981898 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 4 | These highlights do not include all the information needed to use Bepotastine Besilate Ophthalmic Solution safely and effectively. See full prescribing information for Bepotastine Besilate Ophthalmic Solution. Bepotastine Besilate Ophthalmic Solution, for topical ophthalmic use Initial U.S. Approval: 2009 | 20240820 |
| 70430ab5-cd0a-451e-acab-347a2f981898 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 4 | These highlights do not include all the information needed to use Bepotastine Besilate Ophthalmic Solution safely and effectively. See full prescribing information for Bepotastine Besilate Ophthalmic Solution. Bepotastine Besilate Ophthalmic Solution, for topical ophthalmic use Initial U.S. Approval: 2009 | 20240820 |
| f68306a9-80ec-4bc5-8c00-1e1328f21e36 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE Besilate Ophthalmic Solution 1.5% for topical ophthalmic use Initial U.S. Approval: 2009 | 20230721 |
| f68306a9-80ec-4bc5-8c00-1e1328f21e36 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE Besilate Ophthalmic Solution 1.5% for topical ophthalmic use Initial U.S. Approval: 2009 | 20230721 |
| f68306a9-80ec-4bc5-8c00-1e1328f21e36 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE Besilate Ophthalmic Solution 1.5% for topical ophthalmic use Initial U.S. Approval: 2009 | 20230721 |
| 75178670-aa57-45f9-94d5-efcf8305e683 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE BESILATE ophthalmic solution, for topical application in the eye Initial U.S. Approval: 2009 | 20180320 |
| 75178670-aa57-45f9-94d5-efcf8305e683 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE BESILATE ophthalmic solution, for topical application in the eye Initial U.S. Approval: 2009 | 20180320 |
| 75178670-aa57-45f9-94d5-efcf8305e683 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 4 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE BESILATE ophthalmic solution, for topical application in the eye Initial U.S. Approval: 2009 | 20180320 |
| de111d74-c740-47b3-adc7-4b855df2c561 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE Besilate Ophthalmic Solution 1.5% for topical ophthalmic use Initial U.S. Approval: 2009 | 20230721 |
| de111d74-c740-47b3-adc7-4b855df2c561 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE Besilate Ophthalmic Solution 1.5% for topical ophthalmic use Initial U.S. Approval: 2009 | 20230721 |
| de111d74-c740-47b3-adc7-4b855df2c561 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE Besilate Ophthalmic Solution 1.5% for topical ophthalmic use Initial U.S. Approval: 2009 | 20230721 |
| 995f4fe0-d861-4137-8090-a8ffc71c46f4 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE BESILATE OPHTHALMIC SOLUTION, 1.5%, for topical ophthalmic use Initial U.S. Approval: 2009 | 20201231 |
| 995f4fe0-d861-4137-8090-a8ffc71c46f4 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE BESILATE OPHTHALMIC SOLUTION, 1.5%, for topical ophthalmic use Initial U.S. Approval: 2009 | 20201231 |
| 995f4fe0-d861-4137-8090-a8ffc71c46f4 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BEPOTASTINE BESILATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION. BEPOTASTINE BESILATE OPHTHALMIC SOLUTION, 1.5%, for topical ophthalmic use Initial U.S. Approval: 2009 | 20201231 |
| 7c77517f-24c7-4778-94a7-873d11c3c657 | bepotastine besilate 1.5 % Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 2009 | 20090801 |
| 7c77517f-24c7-4778-94a7-873d11c3c657 | bepotastine besilate 15 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 2009 | 20090801 |
| 7c77517f-24c7-4778-94a7-873d11c3c657 | bepotastine besilate 1.5 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 2009 | 20090801 |